J Melville Engle - Net Worth and Insider Trading
J Melville Engle Net Worth
The estimated net worth of J Melville Engle is at least $8,564 dollars as of 2024-09-20. J Melville Engle is the Director of Predictive Oncology Inc and owns about 10,170 shares of Predictive Oncology Inc (POAI) stock worth over $8,564. J Melville Engle is also the Chairman & CEO of ThermoGenesis Holdings Inc and owns about 0 shares of ThermoGenesis Holdings Inc (THMO) stock worth over $0. Details can be seen in J Melville Engle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J Melville Engle has not made any transactions after 2022-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of J Melville Engle
J Melville Engle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J Melville Engle owns 3 companies in total, including Predictive Oncology Inc (POAI) , ThermoGenesis Holdings Inc (THMO) , and Tenax Therapeutics Inc (TENX) .
Click here to see the complete history of J Melville Engle’s form 4 insider trades.
Insider Ownership Summary of J Melville Engle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| POAI | Predictive Oncology Inc | 2022-05-24 | director |
| THMO | ThermoGenesis Holdings Inc | 2011-03-10 | CEO |
| TENX | Tenax Therapeutics Inc | 2010-01-15 | director |
J Melville Engle Latest Holdings Summary
J Melville Engle currently owns a total of 2 stocks. Among these stocks, J Melville Engle owns 10,170 shares of Predictive Oncology Inc (POAI) as of May 24, 2022, with a value of $8,564 and a weighting of 100%. J Melville Engle also owns 0 shares of ThermoGenesis Holdings Inc (THMO) as of March 10, 2011, with a value of $0 and a weighting of 0%.
Latest Holdings of J Melville Engle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| POAI | Predictive Oncology Inc | 2022-05-24 | 10,170 | 0.84 | 8,564 |
| THMO | ThermoGenesis Holdings Inc | 2011-03-10 | 0 | 0.16 | 0 |
Holding Weightings of J Melville Engle
J Melville Engle Form 4 Trading Tracker
According to the SEC Form 4 filings, J Melville Engle has made a total of 1 transactions in Predictive Oncology Inc (POAI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Predictive Oncology Inc is the acquisition of 7,975 shares on May 24, 2022, which cost J Melville Engle around $59,015.
According to the SEC Form 4 filings, J Melville Engle has made a total of 0 transactions in ThermoGenesis Holdings Inc (THMO) over the past 5 years. The most-recent trade in ThermoGenesis Holdings Inc is the acquisition of 2 shares on March 10, 2011, which cost J Melville Engle around $51,750.
Insider Trading History of J Melville Engle
- 1
J Melville Engle Trading Performance
GuruFocus tracks the stock performance after each of J Melville Engle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Melville Engle is 12.77%. GuruFocus also compares J Melville Engle's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Melville Engle within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J Melville Engle's insider trading performs compared to the benchmark.
Performance of J Melville Engle
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.34 | | | | | |
| Relative Return to S&P 500(%) | 15 | | | | | |
J Melville Engle Ownership Network
J Melville Engle Owned Company Details
What does Predictive Oncology Inc do?
Who are the key executives at Predictive Oncology Inc?
J Melville Engle is the director of Predictive Oncology Inc. Other key executives at Predictive Oncology Inc include CHIEF FINANCIAL OFFICER Robert L Myers , Chief Business Officer Pamela Bush , and 10 percent owner Carl I. Schwartz .
Predictive Oncology Inc (POAI) Insider Trades Summary
Over the past 18 months, J Melville Engle made no insider transaction in Predictive Oncology Inc (POAI). Other recent insider transactions involving Predictive Oncology Inc (POAI) include a net sale of 10,000 shares made by Nuzum Charles Lee Sr ,
In summary, during the past 3 months, insiders sold 0 shares of Predictive Oncology Inc (POAI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,000 shares of Predictive Oncology Inc (POAI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 10,000 shares.
Predictive Oncology Inc (POAI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Predictive Oncology Inc Insider Transactions
J Melville Engle Mailing Address
Above is the net worth, insider trading, and ownership report for J Melville Engle. You might contact J Melville Engle via mailing address: 1 Remington Court, Napa Ca 94558.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
